{"url_path":"/sec/evh/8-k/2026-06-04/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1628908/0001628908-26-000037-index.html","accession_number":"0001628908-26-000037","cik":"0001628908","ticker":"EVH","issuer_name":"Evolent Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1628908/0001628908-26-000037-index.html","primary_entity_key":"0001628908","primary_entity_name":"Evolent Health, Inc."},"word_count":335,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders\n\n(a)     Evolent Health, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) on June 4, 2026. At the 2026 Annual Meeting, the Company’s stockholders voted on four proposals. The proposals are described in the Company’s definitive proxy statement on Schedule 14A for the 2026 Annual Meeting filed with the Securities and Exchange Commission on April 24, 2026.\n\n(b)     The final voting results with respect to each proposal voted upon at the 2026 Annual Meeting are set forth below.\n\nProposal 1\n\nThe Company’s stockholders elected ten director nominees named in the proxy statement to the Board of Directors for a one-year term expiring at the Company’s 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, as set forth below:\n\nForAgainstAbstentionsBroker\nNon-Votes\n\nToyin Ajayi, MD60,373,601 5,912,292 90,502 15,840,303 \n\nCraig Barbarosh65,818,775 467,147 90,471 15,840,305 \n\nSeth Blackley 60,323,961 5,993,625 58,810 15,840,302 \n\nRussell Glass60,316,659 5,982,067 77,670 15,840,302 \n\nPeter Grua60,324,441 5,961,459 90,496 15,840,302 \n\nShawn Guertin65,881,893 396,849 97,653 15,840,303 \n\nRichard Jelinek60,027,846 6,269,584 78,965 15,840,303 \n\nKim Keck60,178,555 6,131,979 65,860 15,840,304 \n\nJill Smith65,919,489 402,133 54,773 15,840,303 \n\nBrendan Springstubb65,810,202 468,292 97,900 15,840,304 \n\nProposal 2\n\nThe Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 as set forth below:\n\nFor Against Abstentions\n\n82,036,843124,36255,493\n\nProposal 3\n\nThe Company’s stockholders approved the compensation of our named executive officers for 2025 on an advisory basis, as set forth below:\n\nFor Against AbstentionsBroker\nNon-Votes\n\n58,369,4737,922,80284,11915,840,304\n\nProposal 4\n\nThe Company’s stockholders approved the amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan, as set forth below:\n\nFor Against AbstentionsBroker\nNon-Votes\n\n47,536,87318,712,636126,88515,840,304\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nEvolent Health, Inc.\n\nDate: June 4, 2026/s/ Jonathan D. Weinberg\n\nJonathan D. Weinberg\n\nGeneral Counsel and Secretary"}